the aid library

Filter

11019

Strengthening capacity for noncommunicable disease implementation research in the WHO European Region (2019)

World Health Organization WHO, Regional Office of Europe (2019) C_WHO

Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-informed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving ... more

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19: interim guidance, 20 December 2021

World Health Organization WHO (2022) C_WHO

27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunizatio ... more

Strategic Plan of Action and Budget 2016 – 2025 for Elimination of Onchocerciasis in Africa

World Health Organization World Health Organization WHO African Prgramme for Onchocerciasis Control (2012) C_WHO

The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 perce ... more

Using recency assays for HIV surveillance: 2022 technical guidance

World Health Organization WHO (2022) C_WHO

Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat ... more

COVID-19 natural immunity

World Health Organization WHO (2021) C_WHO

10 May 2021 This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020. This update is focused on what is currently understood about SARS-CoV-2 immunity from ... more

Integrated surveillance of antimicrobial resistance in foodborne bacteria

World Health Organization WHO (2017) C_WHO

Application of a One Health approach . The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countr ... more

Pregnancy management in the context of Zika virus. Interim Guidance. Updated May 2016
recommended

World Health Organization WHO (2016) C_WHO

The aim of this document is to provide interim guidance for interventions to reduce the risk of maternal Zika virus infection and to manage potential complications during pregnancy. This guidance is based on the best available research evidence and ... more

Essentials For Emergencies

World Health Organization (2004) C_WHO

The purpose of this booklet is to assist WHO and other Public Health workers in the field when an emergency occurs. The booklet provides technical hints on how to carry out a rapid ... more

Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya, and Zika

Pan American Health Organisation PAHO (2022) C_WHO

Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid ... more

People-centred framework for tuberculosis programme planning and prioritization, User guide

World Health Organization WHO (2019) C_WHO

The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for ... more

Preliminary Stakeholder Engagement Plan (SEP)

India COVID-19 Emergency Response and Health Systems Preparedness Project (P173836) Ministery of Health and Familiy Welfare - Government of India (2020) C2

A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On ... more

National integrated comprehensive cholera prevention and control plan. Fiscal years (2017/18-2021/22)

Ministry of Health, Republic of Uganda World Health Organisation (WHO); UNICEF (2017) C1

The National Integrated Comprehensive Cholera Prevention and Control Plan (2017-2022) outlines Uganda's strategy to reduce cholera cases and mortality by 50% by 2022. The plan focuses on improving access to clean water, sanitation, and hygiene (WASH ... more

Malaria rapid diagnostic tests, second edition: Technical specifications series for submission to WHO prequalification – diagnostic assessment

World Health Organization WHO (2025) C_WHO

This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnost ... more

Malaria rapid diagnostic tests, 2nd edition - Technical specifications series for submission to WHO prequalification – diagnostic assessment

World Health Organization WHO (2025) C_WHO

This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnost ... more

Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed setting

World Health Organization WHO (2023) C_WHO

Polic brief. In this policy brief, we give an update on those parts of the guidelines which are relevant for people in prisons and other closed setting

Ethical considerations for vaccination programmes in acute humanitarian emergencies

Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al. World Health Organization (2013)

Humanitarian emergencies result in a breakdown of critical health-care services and often make vulnerable communities dependent on external agencies for care. In resource-constrained settings, this ... more

Tracking Progress for Breastfeeding Policies and Programmes: Global breastfeeding scorecard 2017

World Health Organization WHO, UNICEF (2018) C_WHO

WHO and UNICEF have established recommendations for breastfeeding practices. Although every mother decides how to feed her child, this decision is strongly influenced by economic, environmental, social and political factors. The Global Breastfeeding Scorecard analyzes indicators ... more

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... al population-based interventions to reduce CVD risk factors in the entire population. Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs. Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management. Conclusion: The large burden of CVD in LMICs and the fact that persons with high CVD can be identified and managed along cost-effective interventions mean that health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level. more

Covid-19 and NCDs

World Health Organization WHO (2021) C_WHO

Assessment of non-communicable diseases (NCDs) service disruptions during the COVID-19 pandemic. Preliminary results. Guidance on how to provide continuity for NCD programmes:• How to include NCDs in public ... more

WHO Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization WHO (2015) C_WHO

WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regi ... more